EWCongressional Stock Trades
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Congressional stock trades in Edwards Lifesciences Corp (EW) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
8
Politicians Trading
6
Last Traded
Aug 3, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Sep 4, 2026 | Aug 3, 2026 | Sell | $1,001 - $15,000 | +7.17% |
| Josh GottheimerD | Dec 29, 2025 | Nov 19, 2025 | Sell | $1,001 - $15,000 | +10.66% |
Price History
About Edwards Lifesciences Corp
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
6 members of Congress have disclosed 8 trades in Edwards Lifesciences Corp (EW). Most active: Bruce Westerman (2), Jefferson Shreve (2), Alan Armstrong (1).
Across all disclosures, members of Congress reported 4 purchases and 4 sales of Edwards Lifesciences Corp (EW). The most recent trade was on Aug 3, 2026.
Alan Armstrong disclosed buying Edwards Lifesciences Corp (EW) on Mar 27, 2026, valued at $1,001 - $15,000.
Ro Khanna disclosed selling Edwards Lifesciences Corp (EW) on Aug 3, 2026, valued at $1,001 - $15,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.